Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 9
2012 10
2013 10
2014 8
2015 7
2016 6
2017 3
2018 5
2019 7
2020 3
2021 6
2022 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Impact of different age ranges on the benefits and harms of the breast cancer screening programme by the EU-TOPIA tool.
Pinto-Carbó M, Vanaclocha-Espí M, Martín-Pozuelo J, Romeo-Cervera P, Hernández-García M, Ibáñez J, Castán-Cameo S, Salas D, van Ravesteyn NT, de Koning H, Zurriaga Ó, Molina-Barceló A. Pinto-Carbó M, et al. Among authors: salas d. Eur J Public Health. 2024 Apr 5:ckae068. doi: 10.1093/eurpub/ckae068. Online ahead of print. Eur J Public Health. 2024. PMID: 38578614
Construction of an individual socioeconomic status index for analysing inequalities in colorectal cancer screening.
Vanaclocha-Espí M, Pinto-Carbó M, Martín-Pozuelo J, Romeo-Cervera P, Peiró-Pérez R, Barona C, Ortiz F, Nolasco A, Castán S, Salas D, Molina-Barceló A. Vanaclocha-Espí M, et al. Among authors: salas d. PLoS One. 2022 Dec 1;17(12):e0278275. doi: 10.1371/journal.pone.0278275. eCollection 2022. PLoS One. 2022. PMID: 36454740 Free PMC article.
Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain.
Sánchez-Saez F, Peiró S, Cuenca L, Vanaclocha H, Limón R, Salas D, Burgos JS, Sánchez-Payá J, Meneu R, Díez J, García-Sempere A, Navarro IH, Rodríguez-Bernal C, Sanfélix-Gimeno G, Navarro D; Valencian vaccine research program (ProVaVac) study group. Sánchez-Saez F, et al. Among authors: salas d. Vaccine. 2022 Sep 29;40(41):5942-5949. doi: 10.1016/j.vaccine.2022.08.028. Epub 2022 Aug 29. Vaccine. 2022. PMID: 36068110 Free PMC article.
SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I, Bellido-Blasco JB, Gimeno C, Burgos JS, Albert E, Moya-Malo R, Gascó-Laborda JC, Tornero A, Soriano J, Meseguer-Ferrer N, Martínez-Serrano M, Ortíz-Rambla J, Buj H, Hernández N, Peiró S, Salas D, Limón R, Vanaclocha H, Sánchez-Payá J, Díez-Domingo J, Comas I, González-Candelas F, Navarro D; Valencian vaccine research program (ProVaVac) study group. Torres I, et al. Among authors: salas d. J Med Virol. 2022 Aug;94(8):3776-3782. doi: 10.1002/jmv.27799. Epub 2022 Apr 27. J Med Virol. 2022. PMID: 35445415 Free PMC article.
Severe Acute Respiratory Syndrome Coronavirus 2 Adaptive Immunity in Nursing Home Residents Following a Third Dose of the Comirnaty Coronavirus Disease 2019 Vaccine.
Giménez E, Albert E, Zulaica J, Torres I, Rusu L, Moreno AR, Burgos JS, Peiró S, Salas D, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F, Geller R, Navarro D; Valencian Vaccine Research Program (ProVaVac) Study Group. Giménez E, et al. Among authors: salas d. Clin Infect Dis. 2022 Aug 24;75(1):e865-e868. doi: 10.1093/cid/ciac223. Clin Infect Dis. 2022. PMID: 35314856 Free PMC article.
SARS-CoV-2 adaptive immunity in nursing home residents up to eight months after two doses of the Comirnaty® COVID-19 vaccine.
Giménez E, Albert E, Burgos JS, Peiró S, Salas D, Vanaclocha H, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Comas I, Gonzáles-Candelas F; Valencian vaccine research program (ProVaVac) study group. Giménez E, et al. Among authors: salas d. J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.02.035. Epub 2022 Mar 2. J Infect. 2022. PMID: 35245583 Free PMC article.
Risk of Colorectal Cancer and Advanced Polyps One Year After Excision of High-Risk Adenomas.
Medina-Prado L, Mangas-Sanjuan C, Baile-Maxía S, Martínez-Roca AA, Murcia Ó, Zarraquiños S, Rodríguez-Camacho E, Aginagalde AH, Álvarez-Urturi C, Valverde-Roig MJ, Zapater P, Bujanda L, Salas D, Portillo I, Pellisé M, Cubiella J, Jover R. Medina-Prado L, et al. Among authors: salas d. Dis Colon Rectum. 2022 Sep 1;65(9):1112-1120. doi: 10.1097/DCR.0000000000002068. Epub 2021 Nov 22. Dis Colon Rectum. 2022. PMID: 34840293
Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study).
Hernández-García M, Molina-Barceló A, Vanaclocha-Espi M, Zurriaga Ó, Pérez-Gómez B, Aragonés N, Amiano P, Altzibar JM, Castaño-Vinyals G, Sala M, Ederra M, Martín V, Gómez-Acebo I, Vidal C, Tardón A, Marcos-Gragera R, Pollán M, Kogevinas M, Salas D. Hernández-García M, et al. Among authors: salas d. Cancer Causes Control. 2022 Jan;33(1):125-136. doi: 10.1007/s10552-021-01511-4. Epub 2021 Nov 24. Cancer Causes Control. 2022. PMID: 34817770 Free PMC article.
Immunological response against SARS-CoV-2 following full-dose administration of Comirnaty® COVID-19 vaccine in nursing home residents.
Albert E, Burgos JS, Peiró S, Salas D, Vanaclocha H, Giménez E, Limón R, Alcaraz MJ, Sánchez-Payá J, Díez-Domingo J, Navarro D; Valencian Vaccine Research Programme (ProVaVac) Study Group. Albert E, et al. Among authors: salas d. Clin Microbiol Infect. 2022 Feb;28(2):279-284. doi: 10.1016/j.cmi.2021.09.031. Epub 2021 Oct 5. Clin Microbiol Infect. 2022. PMID: 34619398 Free PMC article.
73 results